Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice

Background. Clinical guidelines for the treatment of rheumatoid arthritis (RA) recommend reducing the use of glucocorticoids (GCs) due to the high risk of associated complications. Aim. To determine the frequency of GC cancellations and dose reductions in real clinical practice, while taking into...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alena S. Potapova, Andrey E. Karateev, Elena Yu. Polishchuk, Ekaterina S. Filatova, Vera N. Amirdzhanova, Aleksander M. Lila
Formato:	Artigo
Idioma:	Russo
Publicado em:	"Consilium Medicum" Publishing house 2024-06-01
coleção:	Терапевтический архив
Assuntos:	rheumatoid arthritis disease-modifying antirheumatic drugs biologic disease-modifying antirheumatic drugs janus kinase inhibitor glucocorticoids withdrawal dose reduction
Acesso em linha:	https://ter-arkhiv.ru/0040-3660/article/viewFile/631998/pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!